Trump Administration Seeks to Dismiss Lawsuit Against Mifepristone Access
The Trump administration aims to dismiss a lawsuit from GOP states challenging telehealth access to mifepristone, citing lack of legal standing.
The request continues the Biden administration's position in defense of the drug: that Texas isn't the proper venue for the lawsuit.
Trump admin continues Biden defense of abortion drug mifepristone, asks court to dismiss lawsuit
FOX News·9d
·Mostly ReliableThis source is generally reliable but sometimes includes opinion, propaganda, or minor inaccuracies.Leans RightThis outlet slightly leans right.The legal battle over mifepristone was initially filed by a group of anti-abortion rights doctors and medical associations in November 2022.
Trump administration urges judge to toss states' lawsuit over access to abortion pill mifepristone
CBS News·9d
·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.CenterThis outlet is balanced or reflects centrist views.Nothing is stopping the states from filing the lawsuit someplace else, attorney Daniel Schwei wrote, but the venue has to have some connection to the claims being made.
Trump administration asks judge to toss suit restricting access to abortion medication
Associated Press·9d
·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.CenterThis outlet is balanced or reflects centrist views.The justice department and the office of Missouri’s attorney general, Andrew Bailey, did not immediately respond to requests for comment.
Trump to continue Biden's court defense of abortion drug mifepristone
The Guardian·9d
·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.Leans LeftThis outlet slightly leans left.
Summary
The Trump administration is asking a Texas federal judge to dismiss a lawsuit from Missouri, Idaho, and Kansas that seeks to limit access to mifepristone, a medication abortion drug. The Justice Department argues the states lack legal standing and connection to Texas, asserting that the states can pursue their claims elsewhere. This follows previous Supreme Court rulings these states failed to establish harm related to the FDA's regulations expanding mifepristone access. The legal battle highlights ongoing tensions regarding abortion access and state versus federal authority.
Perspectives
This story is either non-partisan or does not have the required sources to create partisan perspectives.